DNA Vaccine Market Size, Growth, Analysis, Trends & Forecast to 2022 DNA Vaccine Market Size, Growth, Analysis 2017 | Page 5

Table 12-1: Novartis International AG - Product Portfolio
Table 12-2: Novartis International AG - Pipeline Analysis
Table 12-3: Novartis - Key Financials (Million US$), 2013-2015
Table 12-4: Merck & Co. Inc - Product Portfolio
Table 12-5: Merck & Co. Inc - Key Financials (Million US$), 2013-2015
Table 12-6: GlaxoSmithKline - Product Portfolio
Table 12-7: GlaxoSmithKline - Key Financials (Million US$), 2013-2015
Table 12-8: Sanofi - Product Portfolio
Table 12-9: Sanofi - Pipeline Analysis
Table 12-10: Sanofi - Key Financials (Million US$), 2013-2015
Table 12-11: Zoetis - Product Portfolio
Table 12-12: Zoetis - Key Financials (Million US$), 2013-2015
Table 12-13: Green Cross Corporation - Product Portfolio
Table 12-14: Green Cross Corporation - Key Financials (Million US$), 2013-2015
Table 12-15: Inovio Pharmaceuticals - Key Financials (Million US$), 2013-2015
Table 12-16: Inovio Pharmaceuticals - Pipeline Analysis
Table 12-17: Bharat Biotech - Product Portfolio
Table 12-18: Protein Sciences Corporation - Product Portfolio
Table 12-19: Protein Sciences Corporation - Pipeline Analysis
Table 12-20: Indian Immunologicals Ltd. - Product Portfolio
Table 12-21: Serum Institute of India Pvt. Ltd. - Product Portfolio
Table 12-22: Serum Institute of India Ltd. - Pipeline Analysis
Follow Us: